Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for mutational analysis of EGFR in lung carcinoma.
Marchetti A, Normanno N; AIOM - SIAPEC-IAP; Pinto C, Taddei GL, Adamo V, Ardizzoni A, Botti G, Bardelli A, Comin C, Crinò L, Fontanini G, Gambacorta M, Marchetti A, Murer B, Normanno N, Nappi O; Italian Association of Medical Oncology; Italian Society of Anatomic Pathology and Diagnostic Cytopathology. Marchetti A, et al. Pathologica. 2010 Jun;102(3):119-26. Pathologica. 2010. PMID: 21171518 English, Italian. No abstract available.
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, Pistelli F, Comin C, Deliperi A, Grazzini M, Innocenti F, Maddau C, Vella A, Vaggelli L, Paci E, Mascalchi M; ITALUNG Study Research Group. Lopes Pegna A, et al. J Thorac Oncol. 2013 Jul;8(7):866-75. doi: 10.1097/JTO.0b013e31828f68d6. J Thorac Oncol. 2013. PMID: 23612465 Free article. Clinical Trial.
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy.
Minari R, Bordi P, Del Re M, Facchinetti F, Mazzoni F, Barbieri F, Camerini A, Comin CE, Gnetti L, Azzoni C, Nizzoli R, Bortesi B, Rofi E, Petreni P, Campanini N, Rossi G, Danesi R, Tiseo M. Minari R, et al. Among authors: comin ce. Lung Cancer. 2018 Jan;115:21-27. doi: 10.1016/j.lungcan.2017.11.011. Epub 2017 Nov 13. Lung Cancer. 2018. PMID: 29290257
Screen-detected multiple primary lung cancers in the ITALUNG trial.
Mascalchi M, Comin CE, Bertelli E, Sali L, Maddau C, Zuccherelli S, Picozzi G, Carrozzi L, Grazzini M, Fontanini G, Voltolini L, Vella A, Castiglione F, Carozzi F, Paci E, Zompatori M, Lopes Pegna A, Falaschi F; ITALUNG Study Research Group. Mascalchi M, et al. Among authors: comin ce. J Thorac Dis. 2018 Feb;10(2):1058-1066. doi: 10.21037/jtd.2018.01.95. J Thorac Dis. 2018. PMID: 29607181 Free PMC article.
Adenocarcinoma classification: patterns and prognosis.
Kuhn E, Morbini P, Cancellieri A, Damiani S, Cavazza A, Comin CE. Kuhn E, et al. Among authors: comin ce. Pathologica. 2018 Mar;110(1):5-11. Pathologica. 2018. PMID: 30259909 Free article. Review.
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population.
Fancelli S, Caliman E, Mazzoni F, Paglialunga L, Gatta Michelet MR, Lavacchi D, Berardi R, Mentrasti G, Metro G, Birocchi I, Delmonte A, Priano I, Comin CE, Castiglione F, Bartoli C, Voltolini L, Pillozzi S, Antonuzzo L. Fancelli S, et al. Among authors: comin ce. Front Oncol. 2022 Nov 14;12:968064. doi: 10.3389/fonc.2022.968064. eCollection 2022. Front Oncol. 2022. PMID: 36452502 Free PMC article.
81 results